Factory Supply CAS 65-28-1 Phentolamine Mesylate Raw Powder Phentolamine Mesylate Anti Hypertensive Phentolamine Mesylate

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: D-sung Phentolamine Mesylate
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Adult
• State: Powder
• Purity: >99%
• Product Name: Phentolamine Mesylate
• Name: Phentolamine Mesylate Powder
• Appearance: White Powder
• Color: White
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Pharmaceutical;Cosmetic;Food Grade
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 65-28-1
• Mf: C18h23n3o4s
• MW: 377.45800
• Einecs: 200-604-6
• Melting Point: 180-182
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-sung
• Origin: Shaanxi Xi′an
• Production Capacity: 1000kg/Month

Product Description

Factory Supply CAS 65-28-1 Phentolamine Mesylate Raw Powder Phentolamine Mesylate Anti Hypertensive Phentolamine Mesylate

Product Description

Product Details

 

Name	Phentolamine Mesylate
CAS No.	65-28-1
Color	White
Appearance	White powder

Phentolamine mesylate is an organic compound with the chemical formula C18H23N3O4S, mainly used as receptor blockers, by blocking α- Receptors and indirect excitations β- Receptors can rapidly dilate surrounding blood vessels, significantly reduce peripheral vascular resistance, increase peripheral blood volume, and improve microcirculation. This product has an exciting effect on the heart, increasing the myocardial contractility, heart rate and cardiac output. Clinically, it is mainly used to treat acute heart failure, vasospasm disease, hand and foot cyanosis, sensitive toxic shock, pheochromocytoma and other diagnostic tests of pulmonary congestion or pulmonary edema, as well as ventricular premature beats.

 

Application&Function

Clinically, it is mainly used to treat acute heart failure, vasospasm disease, hand and foot cyanosis, sensitive toxic shock, pheochromocytoma and other diagnostic tests of pulmonary congestion or pulmonary edema, as well as ventricular premature beats.

Specification